Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Swarbrick

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Diabetes, Obesity & Metabolism|March 12, 2020
A randomized, open-label, active comparator trial assessing the effects of 26 weeks of liraglutide or sitagliptin on cardiovascular function in young obese adults with type 2 diabetesDavid R Webb, Zin Zin Htike, Daniel J Swarbrick, et al.
Diabetes Care|March 30, 2020
Effects of Low-Energy Diet or Exercise on Cardiovascular Function in Working-Age Adults With Type 2 Diabetes: A Prospective, Randomized, Open-Label, Blinded End Point TrialGaurav S Gulsin, Daniel J Swarbrick, Lavanya Athithan, et al.
Clinical Endocrinology|October 3, 2024
Adrenal Vein Sampling for Primary Aldosteronism: Recommendations From the Australian and New Zealand Working GroupJun Yang, Damon A Bell, Richard Carroll, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Diabetes, Obesity & Metabolism|March 12, 2020
A randomized, open-label, active comparator trial assessing the effects of 26 weeks of liraglutide or sitagliptin on cardiovascular function in young obese adults with type 2 diabetesDavid R Webb, Zin Zin Htike, Daniel J Swarbrick, et al.
Diabetes Care|March 30, 2020
Effects of Low-Energy Diet or Exercise on Cardiovascular Function in Working-Age Adults With Type 2 Diabetes: A Prospective, Randomized, Open-Label, Blinded End Point TrialGaurav S Gulsin, Daniel J Swarbrick, Lavanya Athithan, et al.
Clinical Endocrinology|October 3, 2024
Adrenal Vein Sampling for Primary Aldosteronism: Recommendations From the Australian and New Zealand Working GroupJun Yang, Damon A Bell, Richard Carroll, et al.
Pageof 7